What is the reduction in graft loss caused by the non-dihydropyridine CCB group compared to placebo?
The reduction in graft loss caused by the non-dihydropyridine CCB group was not statistically significant (RR: 0.91; 95% CI: 0.61 1.34) compared to placebo (Figure 7307 326).